Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 9,100 shares at $131.53 ($1.2M) on 2021-03-05, disclosed to the SEC on 2021-03-09.
Open-market sale of $1.2M NVCR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.53 | 4,550 | $598K | 50.0% |
| 2 | $131.53 | 4,550 | $598K | 50.0% |
| Total | $131.53 avg | 9,100 | $1.2M | 100% |
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |